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Abstract: Aging is linked to physiological and pathophysiological changes. In this context, 
elderly patients often are frail, which strongly correlates with negative health outcomes and 
disability. Elderly patients are often malnourished, which again is an independent risk factor for 
both frailty and adverse clinical outcomes. Malnutrition and resulting frailty can be prevented 
by adequate nutritional interventions. Yet, use of nutritional therapy can also have negative 
consequences, including a potentially life-threatening metabolic alteration called refeeding 
syndrome (RFS) in high-risk patients. RFS is characterized by severe electrolyte shifts (mainly 
hypophosphatemia, hypomagnesemia and hypokalemia), vitamin deficiency (mainly thiamine), 
fluid overload and salt retention leading to organ dysfunction and cardiac arrhythmias. Although 
the awareness of malnutrition among elderly people is well established, the risk of RFS is often 
neglected, especially in the frail elderly population. This partly relates to the unspecific clinical 
presentation and laboratory changes in the geriatric population. The aim of this review is to 
summarize recently published recommendations for the management of RFS based on current 
evidence from clinical studies adapted with a focus on elderly patients.
Keywords: refeeding syndrome, frail, elderly, management, malnutrition
Introduction
Pathophysiological signs and symptoms, such as functional and mental decline, socio-
economic problems, loss of teeth and changes in the smell and taste senses, occur with 
older age. Some older people become frail over time. Frailty is a biological syndrome 
with multiple dimensions, which results from cumulative declines across multiple 
physiological systems and leads to worse outcomes (disability, poor quality of life) 
due to decreased reserves and low resistance to stressors.1 Frailty is affected by age, 
gender, lifestyle and socioeconomic status, as well as by comorbidities and cogni-
tive and sensory impairments.2–4 However, frailty does not mean disability, which is 
characterized by physical and/or mental limits on activities and social participation; 
instead, it is a form of pre-disability.4,5 Frailty predicts negative clinical outcomes 
(falls, polypharmacy, hospital and nursing home admission) and is associated with a 
higher risk of mortality.6–9 The criteria for frailty syndrome have been defined by Fried 
et al: unintentional weight loss (>5% weight loss over 1 year), self-reported exhaus-
tion, weakness, slow walking speed and low physical activity level. People who meet 
two of these criteria are pre-frail, and those who meet three or more criteria are frail.9
As frailty is a reversible process, it can be positively influenced by adequate 
nutritional support because of the close association between poor nutritional status 
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and frailty syndrome in older adults.10–13 Micronutrient 
deficiencies and low protein intake which leads to sarcope-
nia (the weakening of skeletal muscle tissue and the sub-
sequent functional decline with age) are related to frailty, 
thus increasing the risk of frailty syndrome.1,14 Nutritional 
intervention, together with resistance training, contributes 
to reducing frailty.15–18
Malnutrition is a main topic in the frail elderly population, 
as up to 50% of older people have a high risk for malnutri-
tion. Malnutrition is highly prevalent in European hospitals 
(20–60%) and is especially frequent in geriatric patients. It 
can thus be seen as the cause or the consequence of disease: 
malnutrition can worsen the course of the disease and be 
caused by the disease itself.19–24
Nutritional therapy aims to reduce the negative effects 
of malnutrition, such as higher morbidity, higher complica-
tion rates and thus longer hospital stays and mortality. The 
refeeding syndrome (RFS) is a potential life-threatening 
complication of the nutritional therapy in the replenish-
ment phase. It is known and has been studied for over 70 
years, beginning at the end of World War II with the death 
of many fasting prisoners after they started a normal diet 
again and also shown in Keys’ Minnesota experiment with 
young healthy participants.25–27 From a pathophysiological 
point of view, RFS is an exaggerated response of the mal-
nourished catabolic body to a nutritional therapy, indeed 
to anabolism. The intake of food, and therefore the switch 
from a catabolic to an anabolic metabolism, causes electro-
lyte and fluid disturbances, as well as limitations of organ 
functions.28,29 Symptoms such as heart failure, peripheral 
edema and neurologic disorders can occur. Protein, lipid and 
glucose metabolisms are disturbed, and a lack of vitamins, 
especially thiamine (vitamin B1), occurs. If not treated, 
these disturbances can lead to severe negative effects, from 
multiorgan dysfunction to death.28–32
To date, the awareness of malnutrition in the elderly 
population is well established, whereas the potential life-
threatening risk of RFS is much less known, especially in 
elderly patients.29,33,34 Screening for RFS risk is not com-
monly done. Even when malnutrition is present, the risk of 
RFS is usually neglected or overlooked among hospitalized 
or institutionalized patients.35
Pathophysiology and clinical 
manifestations of RFS
RFS, the exact pathophysiology of which remains unclear, 
mostly occurs within the first 72 hours after the start of 
nutritional therapy and shows a rapid progression. It emerges 
from the switch from a catabolic to an anabolic state after a 
prolonged starving period. During this fasting period, glucose 
oxidation is reduced. Insulin secretion is therefore decreased, 
and glucagon and catecholamine levels are increased.37 Gly-
cogen reserves are consumed.36 Gluconeogenesis starts along 
with lipolysis and proteolysis to maintain energy production. 
As a result, muscle proteins are wasted, as well as vitamin 
and electrolyte stores.36,38 Through lipolysis, blood levels of 
free fatty acids increase, and ketogenesis in the liver is stimu-
lated.38 Therefore, ketone bodies, mainly hydroxybutyrate, 
become the main energy suppliers of the organism (Figure 1).
By the start of the nutritional therapy, carbohydrates are 
the main energy suppliers, and concentration of glucose sud-
denly increases causing hyperglycemia. The insulin secretion 
subsequently increases and stimulates the anabolic processes. 
Intracellular shifts of glucose and electrolytes (phosphate, 
potassium, magnesium) occur, and their blood levels may 
drop severely. These drops can lead to life-threatening spasms 
or arrhythmia.28,30,36,39,40
As previously mentioned, the increased insulin secretion 
causes the intracellular uptake of phosphate. Phosphate is 
important for the intracellular metabolism of macronutrients 
for both energy production, as glucose must be phosphory-
lated to enter glycolysis, and energy transfer. Hypophospha-
temia, the most common definitional criterion of RFS, can 
cause neuromuscular, neurologic, respiratory and/or hemato-
logic problems.36,41 Hypokalemia and hypomagnesemia both 
can cause arrhythmia as well as rhabdomyolysis, paresis, 
confusion and respiratory insufficiency.36
Along with the increased insulin secretion in the early 
phase of refeeding, the kidneys tend to retain sodium, which 
induces water retention indeed. The consecutive rise of 
extracellular volume can lead to peripheral edema and heart 
failure.
Both electrolyte and vitamin deficiencies often arise, pri-
marily due to a lack of thiamine.38 Thiamine is an important 
cofactor in the metabolism of carbohydrates, which allows for 
energy production. It enables the conversion from glucose to 
ATP (Krebs cycle). In cases of thiamine deficiency, glucose 
is converted to lactate by the lactate dehydrogenase, leading 
to metabolic acidosis. Thiamine deficiency thus may lead 
to neurologic (Wernicke’s encephalopathy, dry beriberi) or 
cardiovascular disorders (wet beriberi), together with water 
retention.36
Briefly and according to the long clinical experience of 
the authors, the three main symptoms of RFS are tachycardia, 
tachypnea and edema, but there are many unspecific symp-
toms occurring in the manifestation of RFS.28,36,42
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Current level of evidence on RFS
The overall evidence level regarding RFS is poor, especially 
in the frail elderly patient population. Only few randomized 
controlled studies are available. A recent review of Friedli 
et al summarizes the best actual evidence on hand.42 Based 
on this review, there is an experts’ consensus defining risk 
factors, timely occurrence and a possible algorithm for the 
prevention, diagnosis and treatment of RFS in medical inpa-
tients. However, even though there has been awareness of RFS 
for over 70 years, there is no universally accepted definition 
for it, and there is a lack of strong evidence for incidence 
rates, prevention and therapy.34,43–46 Thus, many cases prob-
ably stay unrecognized and therefore untreated, especially in 
older hospitalized patients, as its clinical manifestations are 
nonspecific and similar to other symptoms in this population 
(eg, weakness, confusion and poor mobility).
The guidelines of the National Institute for Health and 
Care Excellence (NICE) are widely used for the nutritional 
medical support of adults.46 These guidelines give advice on 
the recognition of malnutrition through the management of 
nutritional therapy (oral, enteral or parenteral). The newly 
published experts’ consensus statement based on the review 
on RFS of Friedli et al provides an algorithm for the manage-
ment of patients with nutritional therapy in order to prevent 
and treat RFS.42
Prevention
Nutritional support team
As the early identification of at-risk patients and the rec-
ognition of RFS are crucial, well-trained medical staff are 
needed. Specialized nutritional support teams, consisting of 
physicians, dieticians, nurses and pharmacists, are present in 
many hospitals. These multidisciplinary nutritional support 
teams assist the attending medical staff in the management 
of patients receiving nutritional therapy to optimize the 
patients’ outcome.
Catabolism
and/or
malnutrition
Insulin
Glucagon
Glycogenolysis
Protein catabolism
Gluconeogenesis
Vitamin and
mineral nutrient levels
Hypophosphatemia
Hypomagnesemia
Hypokalemia
Thiamine deficiency
Salt and
water retention
Protein synthesis
Na+ retention      ECV
Glucose uptake
Thiamine use
Intracellular shift of
PO4, Mg and K
Refeeding
Refeeding
syndrome
Carbohydrate as
the main energy source
Insulin secretion
Figure 1 Pathophysiology of the RFS.
Note: Used with permission of the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism and is modified from Stanga et al.29
Abbreviations: RFS, refeeding syndrome; ECv, extracellular volume.
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Risk factors and risk identification
Possible predictors for RFS are analyzed in many studies, for 
example, low energy intake for over 10 days or weight loss over 
15%. Their sensitivity (67%) and specificity (80%) are low.47–49 
Low serum magnesium (<0.7 mmol/L) was the only significant 
predictor in the study of Rio et al.50 Starvation itself is the most 
reliable predictor.50 In addition to oncologic patients, patients 
with eating disorders, patients with limited nutrient absorption 
(after bariatric surgery, with short bowel syndrome), patients 
with chronic vomiting or diarrhea and patients with chronic 
medication also have a higher risk of developing RFS.42,51–55
Older age, high Nutritional Risk Screening (NRS-2002) 
scores (≥3) and comorbidities were found to be risk factors 
for RFS in many studies.35,56 The NICE guidelines even indi-
cate that frail elderly people or older people living alone are 
more likely to be at risk for RFS.46
RFS incidence can be up to 48% in malnourished patients 
and 14% in the geriatric population.57,58 Pourhassan et al 
showed that almost 75% of hospitalized geriatric patients 
with a risk for malnutrition were also at risk for RFS.35 As 
malnutrition is the most predominant and frequent clinical 
condition in elderly patients, there is a high risk for RFS 
for this patient population. Pourhassan et al investigated the 
relationship between the risk for malnutrition and the risk for 
RFS in an elderly population with three common screening 
tools: the NRS-2002 in inpatients, the Malnutrition Uni-
versal Screening Tool (MUST) in outpatients and the Mini 
Nutritional Assessment (MNA) in older institutionalized 
patients.35,59–61 According to the NRS-2002, 74% were at 
risk for malnutrition, and 75.9% thereof were at high risk for 
RFS. According to the MUST score, 49.7% were at risk for 
malnutrition, and 95.4% thereof were at risk for RFS (with 
MUST ≥3: 100%). According to the MNA, 55.8% were at 
risk for malnutrition, and 69.1% of these were at risk for RFS.
According to these results, across all screening methods, 
patients at risk for malnutrition and for RFS had significantly 
higher weight loss in the past 6 months and lower magnesium 
and potassium levels than the malnourished patients not at 
risk for RFS. There were no differences in age or body mass 
index.35 However, the high prevalence of malnutrition in the 
geriatric population may indicate that age is a confounder 
rather than an independent predictive factor of RFS risk.62
RFS can occur with all forms of artificial nutrition; 
however, it is more frequently observed in patients receiving 
enteral nutrition, due to the stimulation of GLP-1, followed by 
parenteral nutrition. RFS is associated with severe complica-
tions but can potentially be avoided.47,50,57 Risk stratification is 
therefore essential before the start of the nutritional therapy 
(Figure 2), which should then be individually adapted accord-
ing to the patient’s risk for RFS.42,46 However, if older patients 
are at risk for malnutrition, there is no need to perform a 
risk stratification. They can be considered at risk for RFS, as 
both the risk of malnutrition and the risk of RFS overlap.35,56
Diagnosis
The definition of RFS is based on serum electrolyte distur-
bances, especially hypophosphatemia, and on clinical symp-
toms.63 Hypophosphatemia is common in elderly geriatric 
patients (14%), if tested, and is related to the occurrence 
of RFS.35,58 It can be especially detrimental in frail elderly 
patients, particularly in those with several comorbidities. It is 
an independent predictor of mortality and causes a threefold 
increase in mortality: the more severe the hypophosphatemia, 
the worse the outcome.58 Based on the algorithm of Friedli 
et al, the diagnosis of RFS is based on hypophosphatemia, 
defined as a decrease in phosphate values >30% under the ini-
tial value or <0.6 mmol/L, or if two other electrolytes decrease 
under their normal values.42 The electrolyte disturbances may 
cause clinical symptoms, such as edema, respiratory insuf-
ficiency or heart insufficiency, together with fluid imbalance 
and micronutrient deficiencies.28,36 The critical timeframe for 
RFS is the first 72 hours. When electrolyte disturbances are 
present alone within 72 hours, it is considered an imminent 
RFS. In case of electrolyte disturbances associated with clini-
cal symptoms within 72 hours, RFS is manifest (Figure 3).
Management
Generally, RFS is a rare complication; nevertheless, nutri-
tional therapy should be adapted depending on the individual 
risk factors of every patient. Figure 4 shows the detailed 
recommendations for the nutritional management of all risk 
categories.42
Fluids
Hydration status is a key point in the management of RFS. 
Thus, prevention and treatment of RFS also means fluid 
management. As Tsiompanou et al showed, even if the aware-
ness for RFS is present and restrictions in energy input and 
rate are made, RFS can occur due to intravenous fluid shifts/
overload.64 Overhydration is an issue, especially in frail elderly 
patients.64 Older patients may suffer from dehydration and 
need fluid resuscitation, but they have an increased risk for 
overhydration due to comorbidities (eg, heart failure) and 
age-related decrease in organ function.64 Also, the choice 
of appropriate fluid is of special importance. Recent studies 
prefer balanced electrolyte solutions to 0.9% NaCl solutions, 
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Initial risk determination for RFS
Major risk factors (B) Very high risk factors (C)
•   BMI <14 kg/m2
•   Weight loss >20%
•   Starvation >15 days
Minor risk = 1 risk factor A
High risk = 2 risk factors A or 1 risk factor B
Very high risk = 1 risk factor C
•   BMI <16 kg/m2
•   Unintentional weight loss
     >15% in the preceding 3–6
     months
•   Very little or no nutritional
     intake for >10 days
•    Low levels of serum
     potassium, phosphate or
     magnesium prior to feed
•   BMI <18.5 kg/m2
•   Unintentional weight loss
     >10% in the preceding 3–6
     months
•   Very little or no nutritional
     intake for >5 days
•    History of alcohol or drug
     abuse
Minor risk factors (A)
Figure 2 Identification of patients at risk for RFS.
Note: Used with permission of the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism and is modified from Friedli et al42 and from National 
institute for Health and Clinical Excellence (NiCE).46
Abbreviations: RFS, refeeding syndrome; BMi, body mass index.
Decrease of PO4 from baseline >30% or <0.6 mmol/L
or
Any two other electrolyte shifts below normal range
     Mg <0.75 mmol/L, PO4 <0.80 mmol/L, K <3.5 mmol/L 
Associated with clinical symptoms?
•   Edema
•   Tachycardia
•   Tachypnea
NO
IMMINENT RFS MANIFEST RFS
YES
YES
Figure 3 Diagnosis of RFS.
Note: Used with permission of the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism and is modified from Friedli et al.42
Abbreviation: RFS, refeeding syndrome.
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Screening: risk for nutritional risk and risk for RFS
Assessment of hydration status and electrolyte check (K, Mg, PO4, Na, Ca)
Risk stratification for RFS according to the risk factors
Low risk for RFS
1 2 3
No risk for RFS
Correction of existing hydration deficits and replacement of previous or ongoing abnormal fluid losses
Preventive measures: electrolyte substitution, thiamine supplementation (at least 30 min before refeeding)
• Nutritional support
• Fluid maintenance
• Administration of micronutrients
• Nutritional support
• Fluid maintenance
• Administration of micronutrients
• Nutritional support
• Fluid maintenance
• Administration of micronutrients
Clinical and laboratory monitoring, management of complications
© UDEM
•    Maintenance of the
     nutritional and hydration
     status according to the
     standards of care
High risk for RFS Very high risk for RFS
A
Nutritional support:
• Day 1–3: 15–25 kcal/kg/d
• Day 4: 30 kcal/kg/d
• From Day 5: full requirements
Fluid management:
• 30–35 mL/kg/d
No sodium restriction
Days 1–3: 200–300 mg thiamine
Days 1–10: Multivitamin
Low risk for RFS High risk for RFS Very high risk for RFS
1B C D2 3
Nutritional support:
• Days 1–3: 10–15 kcal/kg/d
• Days 4–5: 15–25 kcal/kg/d
• Day 6: 25–30 kcal/kg/d
• From Day 7: full requirements
Fluid management:
• Days 1–3: 25-30 mL/kg/d
• From Day 4: 30–35 mL/kg/d
Sodium restriction
• Days 1–7: <1 mmol/kg/d
Days 1–3: 200–300 mg thiamine
Days 1–10: Multivitamin
Nutritional support:
• Days 1–3: 5–10 kcal/kg/d
• Days 4–6: 10–20 kcal/kg/d
• Days 7–9: 20–30 kcal/kg/d
• From Day 10: full requirements
Fluid management:
• Days 1–3: 20–25 mL/kg/d
• Days 4–6: 25–30 mL/kg/d
• From Day 7: 30–35 mL/kg/d
Sodium restriction
• Days 1–10: <1 mmol/kg/d
Days 1–5: 200–300 mg thiamine
Days 1–10: Multivitamin
Figure 4 Management of nutritional therapy in patients at risk for RFS: (A) for patients of all risk categories; (B) for patients at low risk; (C) for patients at high risk; (D) 
for patients at very high risk.
Note: Used with permission of the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism and is modified from Friedli et al.42
Abbreviation: RFS, refeeding syndrome.
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except in cases of fluid loss over a stoma or fistula.65 The 
sodium retention due to insulin secretion after the refeeding 
leads to extracellular volume expansion and vasoconstric-
tion.66 Salt restrictions (Na <1 mmol/kg body weight per day) 
are therefore needed in patients with (very) high risk for RFS 
to encounter this phenomenon. A fluid input of 20–25 mL/kg 
body weight per day is generally needed to maintain the bal-
ance. In cases of fluid and/or salt restrictions, it is important to 
take into account the volume and the amount and salt content 
of the intravenous solution (up to 6 g/L in Ringer’s lactate 
solution or 9 g in 0.9% NaCl solution) and the intravenously 
administered drugs, as well as parenteral nutrition.65
Energy
Most studies as well as the NICE guidelines recommend start-
ing nutritional therapy with low caloric input and increasing 
step by step over 5–10 days, according to the individual’s risk 
of RFS and clinical features.28,46,67–70 Given the small number 
of extant randomized studies, this approach shows the best 
evidence level available.43 It is recommended to start nutri-
tional support with an amount of 5–15 kcal/kg body weight 
per day (40–60% carbohydrate, 30–40% fat and 15–20% 
protein), depending on the risk category.
Micronutrients
As mentioned, the refeeding of catabolic patients causes an 
intracellular shift of electrolytes and vitamins (mainly thia-
mine), the stores of which may be empty. Blood levels drop 
subsequently. Therefore, it is very important to replete elec-
trolyte levels before the start of the nutritional therapy. This 
step is especially important for phosphate and thiamine.36,42 
Supplementation should therefore be started in a preventive 
manner, even for normal phosphate levels. As fat oxidation 
does not require phosphate-containing products, phosphate 
stores of the body can be completely depleted while circulat-
ing levels are within the normal range.36 Frequent assessment 
of phosphate levels is thus mandatory before and during 
refeeding to avoid RFS or minimize its consequences, as 
hypophosphatemia plays a key role in RFS.29,36,71
Thiamine administration is essential as its body stores 
rapidly decrease. High-dose thiamine (200–300 mg) should 
be given 30 minutes before the start of the refeeding, at the 
latest. Other vitamins should be supplemented to 200% of the 
recommended daily intake (RDI), and trace elements should 
be supplemented to 100% of the RDI.
Other electrolytes, especially magnesium and potassium, 
should be supplemented according to blood levels. Magnesium 
is mandatory for the activity of the cellular sodium–potassium 
pump and is therefore important for the reabsorption of potas-
sium. Therefore, hypomagnesemia should always be corrected 
when present with hypokalemia; otherwise, the hypokalemia 
cannot be corrected, and there is a potassium refractory state.72
In contrast, iron should not be supplemented within the 
first 7 days of nutritional support, as iron administration sup-
ports blood production, which increases potassium needs, 
and hypokalemia can be worsened. Further, parenteral iron 
substitution should be considered with caution in catabolic 
patients, as parenteral iron supplementation can induce and/
or prolong hypophosphatemia.73
If the electrolyte levels drop severely during the nutri-
tional therapy (imminent RFS), they must be repleted 
adequately. In cases of manifest RFS, electrolyte repletion 
should be intensified, and nutritional therapy (energy and 
fluids) should be reduced, according to the highest risk 
category. Thus, clinical symptoms must be treated. Table 1 
shows the possible repletion protocol.
Table 1 Suggested supplementation regimen28,29,74–78
Potassium Magnesium Phosphate
Mild 
deficiency
3.1–3.5 mmol/L 0.5–0.7 mmol/L 0.61–0.8 mmol/L
Oral replacement with 20 mmol (as KCl 
or other salts) or i.v. replacement with 
20 mmol KCl over 4–8 hours. Check levels 
the next day
Oral replacement with 10–15 mmol Mg-
chloride or Mg-citrate or Mg-l-aspartate
Oral replacement with 0.3 mmol/kg/d PO4 
(divided doses to minimize diarrhea) or i.v. 
replacement with 0.3 mmol/kg/d PO4 (as 
K3PO4 or Na3PO4) over 8–12 hours. Check 
levels the next day
Oral Mg should be given in divided doses 
to minimize diarrhea (absorption process 
is saturated at about 5–10 mmol Mg)
Moderate 
deficiency
2.5–3.0 mmol/L 0.32–0.6 mmol/L
i.v. replacement with 20–40 mmol KCl over 
4–8 hours. Check levels after 8 hours, if not 
normal levels, give further 20 mmol KCl
i.v. replacement with 0.6 mmol/kg/d PO4 (as 
K3PO4 or Na3PO4) over 8–12 hours. Check 
levels after 8–12 hours and repeat infusion if 
necessary (max. of 50 mmol PO4 in 24 hours)
Severe 
deficiency
<2.5 mmol/L <0.5 mmol/L <0.32 mmol/L
i.v. replacement with 40 mmol KCl over 
4–8 hours. Check levels after 8 hours, if not 
normal levels, give further 40 mmol KCl
i.v. replacement with 20–24 mmol 
MgSO4 (4–6 g) over 4–8 hours. Reassess 
every 8–12 hours
Same replacement therapy as for moderate 
deficiency
Abbreviation: i.v., intravenous.
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Monitoring
The main issue regarding RFS is to be aware of it, to prevent 
it and to be able to diagnose and treat it, as it can occur and 
progress rapidly in the first 72 hours after the beginning of 
the nutritional therapy. Intensive clinical evaluation, including 
vital signs and hydration status, as well as blood levels, is 
mandatory to detect early signs of RFS, such as organ failure 
and fluid overload. The body weight (or fluid balance) should 
be checked daily, as an increase of 0.3–0.5 kg/d (1.5 kg/week) 
could be a sign of pathologic water retention. Laboratory 
measurements of phosphate, thiamine and magnesium levels 
may be uncommon in the elderly population, but they are 
essential in the monitoring of RFS (Figure 5).33
Additional ECG monitoring is recommended during the 
first few days in patients with a very high risk for RFS or 
with severe electrolyte imbalance (K <2.5 mmol/L, PO
4
 <0.32 
mmol/L, Mg <0.5 mmol/L). Severe electrolyte imbalance can 
potentially cause severe arrhythmia and QT prolongations 
up to torsade de pointes, especially in older patients.28,29,42,46
Conclusion
Malnutrition is prevalent in the frail elderly population and is 
a main topic in geriatric medicine. Nutritional therapies are 
widely used to improve the nutritional status of malnourished 
catabolic patients. RFS may develop as a complication of 
nutritional rehabilitation, leading to severe complications 
and becoming potentially life-threatening, especially in the 
frail elderly, if not recognized in a timely manner and treated 
adequately. Thus, as the risk for malnutrition is associated 
with the risk for RFS, awareness of this condition among 
the medical staff treating elderly frail patients must increase. 
Broad randomized clinical studies evaluating nutritional 
therapy and RFS in elderly patients are needed.
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